OTC Markets OTCPK - Delayed Quote USD

BioArctic AB (publ) (BRCTF)

19.00
+0.26
+(1.39%)
At close: June 5 at 8:00:00 PM EDT
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,517,325
257,352
615,995
228,291
23,146
Cost of Revenue
36,192
26,984
14,988
74,326
55,067
Gross Profit
1,481,133
230,368
601,007
153,965
-31,921
Operating Expense
562,388
459,986
344,048
161,903
107,932
Operating Income
918,745
-229,618
256,959
-7,938
-139,853
Net Non Operating Interest Income Expense
15,947
40,845
33,849
1,785
-983
Pretax Income
933,945
-189,519
276,486
-11,167
-140,511
Tax Provision
31,990
-12,440
47,237
11
-20,723
Net Income Common Stockholders
901,956
-177,079
229,249
-11,179
-119,789
Diluted NI Available to Com Stockholders
901,956
-177,079
229,249
-11,179
-119,789
Basic EPS
10.20
--
2.60
-0.13
-1.36
Diluted EPS
10.18
--
2.59
-0.13
-1.36
Basic Average Shares
88,382.35
--
88,230.64
88,074.30
88,059.99
Diluted Average Shares
88,592.08
--
88,487.40
88,682.99
88,579.99
Total Operating Income as Reported
919,847
-228,515
252,640
-17,336
-139,723
Total Expenses
598,580
486,970
359,036
236,229
162,999
Net Income from Continuing & Discontinued Operation
901,956
-177,079
229,249
-11,179
-119,789
Normalized Income
901,956
-177,079
229,249
-11,179
-119,782.18
Interest Income
30,067
40,845
34,228
2,535
0
Interest Expense
14,120
0
328
559
838
Net Interest Income
15,947
40,845
33,849
1,785
-983
EBIT
948,065
-189,519
276,814
-10,608
-139,673
EBITDA
948,065
-178,800
284,253
4,025
-126,566
Reconciled Cost of Revenue
36,192
26,984
14,988
74,326
55,067
Reconciled Depreciation
--
10,719
7,439
14,184
13,045
Net Income from Continuing Operation Net Minority Interest
901,956
-177,079
229,249
-11,179
-119,789
Total Unusual Items Excluding Goodwill
--
--
--
0
-8
Total Unusual Items
--
--
--
0
-8
Normalized EBITDA
948,065
-178,800
284,253
4,025
-126,558
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
-1.18
12/31/2021 - 11/29/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WPDPF WPD Pharmaceuticals Inc.
0.0010
+3,233.33%
 
BRAXF Braxia Scientific Corp.
0.0002
-84.38%
 
KLDO Kaleido Biosciences, Inc.
0.0400
+39,899.33%
 
XRTX XORTX Therapeutics Inc.
0.8920
-2.51%
 
THAR Tharimmune, Inc.
1.6000
+5.97%
 
SPRB Spruce Biosciences, Inc.
0.0600
-0.83%
 
CYCN Cyclerion Therapeutics, Inc.
3.1440
-1.13%
 
CAMP CAMP4 THERAPEUTICS CORPORATION
1.8200
-5.21%
 
ORGS Orgenesis Inc.
2.2700
+22.70%
 
COYA Coya Therapeutics, Inc.
5.88
0.00%